CEO ONAKids (The Collider Programme)

FORESEE; Barcelona; Presencial; EUR 50.000 - 70.000; Jornada completa

Descripción de la vacante

A pioneering health innovation project in Barcelona is seeking a passionate Entrepreneur to lead as CEO & Co-Founder. This role involves business validation for a groundbreaking medical device that enhances neonatal health. The ideal candidate is an experienced entrepreneur in healthtech, skilled in strategy, fundraising, and regulatory pathways. This position offers equity, a stipend, and opportunity for international exposure.

Servicios

Relevant equity as CEO and Co-Founder

€6,000 stipend

Access to a participative loan of up to €50K

International exposure through The Collider ecosystem

Access to a structured programme with mentors

Coworking space in Barcelona

Formación

• Experience founding or co-founding healthtech or medtech startups.
• Familiarity with clinical validation and regulation of medical devices.
• Fluency in English and Spanish, knowledge of Catalan is a plus.

Responsabilidades

• Lead the business validation phase and coordinate clinical validation.
• Define the financial model and business strategy for the spin-off.
• Manage day-to-day operations and execute the commercial roadmap.

Conocimientos

Entrepreneurship

Strategy

Fundraising

Market access

Leadership

Regulatory awareness

Descripción del empleo

Barcelona, Spain Call4Entrepreneurs - The Collider

About the job CEO ONAKids (The Collider Programme)

ONAkids | Early Screening for Language Development Disorders

Are you seeking a new entrepreneurial adventure in health innovation with the opportunity to build a high-impact medtech spin-off?

ONAkids, project developed at the Brainlab Cognitive Neuroscience Research Group (Universitat de Barcelona) with the support of Fundació Bosch i Gimpera, is looking for an entrepreneurial profile with strong business acumen and founder experience to join the team.

As the Entrepreneur, you will be part of our venture-building journey, leading the business validation phase hand-in-hand with the scientific team. At the end of this process, if the business and the team are validated, the spin-off will be incorporatedand you will become the CEO & Co-Founder of a disruptive medical device company transforming neonatal health.

About ONAkids

Language delay affects 1 in 5 children and is associated with long-term difficulties in reading, attention, socialization and mental health. Early detection significantly improves outcomes but today, no neonatal screening tool reliably identifies this risk.

ONAkids has developed an EEG-based medical device that records newborns brain responses to speech sounds and, through cloud-based AI models, provides 80% prediction accuracy for language-development riskenabling early intervention within the first months of life.

The team vision is to position ONAkids as a universal newborn screening tool, comparable in simplicity and cost to current mandatory hearing tests.

Main project achivements so far:

Validated AI algorithms reaching 80% accuracy.

• A protected database of 600 neonatal EEG recordings,with longitudinal follow-up available for approximately 200 cases.
• A dedicated prototype device designed for neonatal clinical use.
• Consistent competitive funding since 2021, securing a total of 400,000 including MICINN, AGAUR, Biocat and CRAASH.

The Entrepreneur will play a critical role in advancing ONAkids by bringing business leadership, regulatory awareness, and strategic execution to build a viable, clinically validated and scalable medical device company. Key challenges include:

• Defining the vision, financial model and business strategy for the future spin-off.
• Leading patient journey definition and selecting the beachhead market.
• Coordinating clinical validation, regulatory pathways (CE/MDR; FDA desirable) and market access.

Securing the first clinical pilots and early adopters.

Leading the first fundraising rounds (public and private).

• Managing day-to-day operations and executing the commercial roadmap.

The Offer

• Relevant equity as CEO and Co-Founder once the company is established.
• 6,000 stipend (3 monthly instalments of 2,000 each).
• Opportunity to access a participative loan of up to 50K to finance the first phases of the project.
• International exposure through The Collider ecosystem (4YFN, Mobile World Congress, corporate & investor networks).
• Access to a structured programme supported by mentors, specialists, healthcare experts, industry partners and investors.
• Coworking space in Barcelona (Tech Barcelona Pier 01).
• Backing from the Universitat de Barcelona, Fundació Bosch i Gimpera, and a highly respected scientific team.

This opportunity is for you If:

• You are an entrepreneur with experience founding or co-founding healthtech/medtech/digital health startups.
• Passionate about science-based innovation, child health and preventative care.

Skilled in strategy, leadership, fundraising, and market access.

• Familiar with medical device development: clinical validation, regulation (MDR/CE), industrialization, go-to-market

Experienced in securing public grants and private investment.

• A resilient, hands-on leader capable of bridging science, clinical practice and business.

Eligible to work in Spain (passport or visa required).

Fluent in English andSpanish; Catalan is a plus.

About the Programme

Founded in 2017, The Collider has supported more than 200 scientific projects, created 23 deep-tech spin-offs, and manages a portfolio valued at 112M, with a 77% survival rate.